Mark S. Williams

Glasgow, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications

Mitochondrial transfer in acute myeloid leukaemia and multiple myeloma: Mechanisms, consequences and potential therapeutic opportunities.

Mitochondrial transfer in acute myeloid leukaemia and multiple myeloma: Mechanisms, consequences and potential therapeutic opportunities.

Journal: The FEBS journal
Published: October 21, 2025

Cancer microenvironment and pharmacological interventions.

Cancer microenvironment and pharmacological interventions.

Journal: British journal of pharmacology
Published: December 26, 2023

Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development.

Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development.

Journal: The Journal of infectious diseases
Published: September 05, 2023

IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma.

IL-10R inhibition reprograms tumor-associated macrophages and reverses drug resistance in multiple myeloma.

Journal: Leukemia
Published: September 16, 2022

Stromal bone marrow fibroblasts and mesenchymal stem cells support acute myeloid leukaemia cells and promote therapy resistance.

Stromal bone marrow fibroblasts and mesenchymal stem cells support acute myeloid leukaemia cells and promote therapy resistance.

Journal: British journal of pharmacology
Published: January 31, 2022

Deletion of TSPO Causes Dysregulation of Cholesterol Metabolism in Mouse Retina.

Deletion of TSPO Causes Dysregulation of Cholesterol Metabolism in Mouse Retina.

Journal: Cells
Published: October 26, 2021

Macrophages in Acute Myeloid Leukaemia: Significant Players in Therapy Resistance and Patient Outcomes.

Macrophages in Acute Myeloid Leukaemia: Significant Players in Therapy Resistance and Patient Outcomes.

Journal: Frontiers in cell and developmental biology
Published: April 15, 2021

Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.

Blast cells surviving acute myeloid leukemia induction therapy are in cycle with a signature of FOXM1 activity.

Journal: BMC cancer
Published: December 01, 2020

Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.

Response to tyrosine kinase inhibitors in myeloid neoplasms associated with PCM1-JAK2, BCR-JAK2 and ETV6-ABL1 fusion genes.

Journal: American journal of hematology
Published: February 05, 2020

Dynamic induction of drug resistance through a stress-responsive enhancer in acute myeloid leukemia.

Dynamic induction of drug resistance through a stress-responsive enhancer in acute myeloid leukemia.

Journal: Molecular & cellular oncology
Published: December 10, 2019

Targeted nanopore sequencing for the identification of ABCB1 promoter translocations in cancer.

Targeted nanopore sequencing for the identification of ABCB1 promoter translocations in cancer.

Journal: BMC cancer
Published: October 03, 2019

A stress-responsive enhancer induces dynamic drug resistance in acute myeloid leukemia.

A stress-responsive enhancer induces dynamic drug resistance in acute myeloid leukemia.

Journal: The Journal of clinical investigation
Published: June 03, 2019
Showing 1-12 of 22

Last Updated: 09/26/2026